S&P 500

5.304,72

0,70%

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Praxis Precision Medicines Inc (PRAX)
Praxis Precision Medicines Inc (PRAX) Notícias

PRAX

Praxis Precision Medicines (PRAX)

Praxis Precision Medicines Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:PRAX

1 2 3 4 5 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
20/05/2024	09:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRAX	Praxis Precision Medicines Inc
13/05/2024	09:21	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PRAX	Praxis Precision Medicines Inc
13/05/2024	09:18	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PRAX	Praxis Precision Medicines Inc
12/04/2024	09:00	GlobeNewswire Inc.	Praxis Precision Medicines to Present on Ulixacaltamide at the American Academy of Neurology 2024 Annual Meeting	NASDAQ:PRAX	Praxis Precision Medicines Inc
05/03/2024	11:08	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:PRAX	Praxis Precision Medicines Inc
05/03/2024	09:33	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:PRAX	Praxis Precision Medicines Inc
05/03/2024	09:12	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:PRAX	Praxis Precision Medicines Inc
14/02/2024	22:45	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:PRAX	Praxis Precision Medicines Inc
12/01/2024	19:20	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:PRAX	Praxis Precision Medicines Inc
10/01/2024	18:19	GlobeNewswire Inc.	Praxis Precision Medicines, Inc. Announces Proposed Public Offering	NASDAQ:PRAX	Praxis Precision Medicines Inc
28/11/2023	09:00	GlobeNewswire Inc.	Praxis Precision Medicines to Showcase Largest Pipeline of Precision Epilepsy Programs and Breadth of Commitment to Epilepsy Treatments at Upcoming Meetings	NASDAQ:PRAX	Praxis Precision Medicines Inc
21/11/2023	18:00	GlobeNewswire Inc.	Praxis Precision Medicines to Present at the Piper Sandler 35th Annual Healthcare Conference	NASDAQ:PRAX	Praxis Precision Medicines Inc
16/11/2023	10:00	GlobeNewswire Inc.	Praxis Precision Medicines Receives PRIME Designation from the EMA for elsunersen (PRAX-222) for Treatment of SCN2A Gain of Function Developmental Epilepsies	NASDAQ:PRAX	Praxis Precision Medicines Inc
07/11/2023	09:00	GlobeNewswire Inc.	Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2023 Financial Results	NASDAQ:PRAX	Praxis Precision Medicines Inc
02/11/2023	09:00	GlobeNewswire Inc.	Praxis Precision Medicines to Present at Truist Securities BioPharma Symposium	NASDAQ:PRAX	Praxis Precision Medicines Inc
16/10/2023	08:09	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:PRAX	Praxis Precision Medicines Inc
04/10/2023	08:56	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:PRAX	Praxis Precision Medicines Inc
02/10/2023	14:17	GlobeNewswire Inc.	Praxis Precision Medicines Provides Portfolio Update at 2023 R&D Day	NASDAQ:PRAX	Praxis Precision Medicines Inc
27/09/2023	17:15	GlobeNewswire Inc.	Praxis Precision Medicines To Host Hybrid R&D Day on Monday, October 2, 2023	NASDAQ:PRAX	Praxis Precision Medicines Inc
19/09/2023	11:25	AllPennyStocks.com	Biotech Catches Major Premarket Bid	NASDAQ:PRAX	Praxis Precision Medicines Inc
07/09/2023	09:00	GlobeNewswire Inc.	Praxis Precision Medicines to Present at H.C. Wainwright 25th Annual Global Investment Conference	NASDAQ:PRAX	Praxis Precision Medicines Inc
31/08/2023	09:00	GlobeNewswire Inc.	Praxis Precision Medicines to Present Data from Epilepsy Portfolio at the 35th International Epilepsy Congress	NASDAQ:PRAX	Praxis Precision Medicines Inc
09/08/2023	08:00	GlobeNewswire Inc.	Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2023 Financial Results	NASDAQ:PRAX	Praxis Precision Medicines Inc
08/08/2023	08:00	GlobeNewswire Inc.	Praxis Precision Medicines Announces Positive Data from Randomized Withdrawal Sub-Study and Long-Term Extension of Essential1 Study for Ulixacaltamide	NASDAQ:PRAX	Praxis Precision Medicines Inc
07/08/2023	08:00	GlobeNewswire Inc.	Praxis Precision Medicines Announces Positive Results of EEG Analysis of PRAX-628 Phase 1 Study	NASDAQ:PRAX	Praxis Precision Medicines Inc
03/08/2023	17:12	GlobeNewswire Inc.	Praxis Precision Medicines to Participate at the 2023 Wedbush PacGrow Healthcare Conference	NASDAQ:PRAX	Praxis Precision Medicines Inc
30/06/2023	17:15	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:PRAX	Praxis Precision Medicines Inc
28/06/2023	17:48	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:PRAX	Praxis Precision Medicines Inc
28/06/2023	17:48	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:PRAX	Praxis Precision Medicines Inc
27/06/2023	11:02	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:PRAX	Praxis Precision Medicines Inc